Halozyme Therapeutics, Inc.
HALONasdaqCIK 1159036HealthcareFiscal year ends Dec 31
Reports and events: 315 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3020:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-26-000128 |
| 2026-09-2220:41 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-398015 |
| 2026-09-1812:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-26-000126 |
| 2026-09-1620:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-26-000121 |
| 2026-08-1820:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-26-000106 |
| 2026-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001159036-26-000104 |
| 2026-08-0620:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000103 |
| 2026-07-0220:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-26-000088 |
| 2026-05-1120:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001159036-26-000068 |
| 2026-05-1120:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000067 |
| 2026-05-0720:16 ET | 8-K | 5.07 Shareholder vote results | 0001159036-26-000057 |
| 2026-04-3012:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-26-000053 |
| 2026-04-2420:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001159036-26-000051 |
| 2026-03-2320:11 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001159036-26-000041 |
| 2026-03-1212:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-26-000035 |
| 2026-02-1721:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001159036-26-000024 |
| 2026-02-1721:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000023 |
| 2026-01-2811:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-26-000011 |
| 2025-12-0921:45 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000070 |
| 2025-12-0822:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000068 |
| 2025-11-2421:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000061 |
| 2025-11-1222:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-277988 |
| 2025-11-0713:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-25-000049 |
| 2025-11-0521:59 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001159036-25-000047 |
| 2025-11-0321:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001159036-25-000045 |
| 2025-11-0321:07 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001159036-25-000044 |
| 2025-10-1410:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001159036-25-000039 |
| 2025-10-0620:58 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000036 |
| 2025-10-0320:51 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-230348 |
| 2025-10-0111:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-225853 |
| 2025-08-0520:09 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001159036-25-000034 |
| 2025-08-0520:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000033 |
| 2025-05-0620:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001159036-25-000026 |
| 2025-05-0620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000025 |
| 2025-05-0220:07 ET | 8-K | 5.07 Shareholder vote results | 0001159036-25-000022 |
| 2025-03-2120:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000020 |
| 2025-03-1820:10 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001159036-25-000016 |
| 2025-02-1821:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001159036-25-000010 |
| 2025-02-1821:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000008 |
| 2025-02-1321:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001159036-25-000005 |
| 2025-01-0813:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-25-000003 |
| 2024-10-3120:07 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001159036-24-000050 |
| 2024-10-3120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000049 |
| 2024-08-0620:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001159036-24-000044 |
| 2024-08-0620:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000043 |
| 2024-05-0720:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001159036-24-000037 |
| 2024-05-0720:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001159036-24-000036 |
| 2024-04-2620:22 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001159036-24-000031 |
| 2024-03-1520:06 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001159036-24-000024 |
| 2024-02-2021:07 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001159036-24-000008 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.